SBH
UTMD icon

Segall Bryant & Hamill’s Utah Medical Products UTMD Stock Holding History

Segall Bryant & Hamill’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.49M Hold
21,547
– – 0.02% 503
2026
Q1 		$1.34M Buy
21,547
+10,065
+88% +$634K 0.02% 467
2025
Q4 		$643K Sell
11,482
-53
-0.5% -$3.07K 0.01% 537
2025
Q3 		$726K Buy
+11,535
New +$682K 0.01% 522

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Segall Bryant & Hamill's UTMD Position: Q2 2026 in Review

Segall Bryant & Hamill held its Utah Medical Products (UTMD) position steady in Q2 2026 at 21,547 shares worth $1.49M. The position accounts for 0.02% of the portfolio, ranked #503.

Segall Bryant & Hamill first reported a position in UTMD in Q3 2025 and has held it in 4 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Segall Bryant & Hamill held 21,547 shares of Utah Medical Products worth $1.49M as of Q2 2026.
  • Segall Bryant & Hamill left its Utah Medical Products share count unchanged in Q2 2026.
  • Utah Medical Products made up 0.02% of Segall Bryant & Hamill's portfolio in Q2 2026, its #503 holding.
  • Segall Bryant & Hamill first reported a position in Utah Medical Products in Q3 2025 and has held it in 4 quarters since.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.